DrugPatentWatch Database Preview
STRENSIQ Drug Profile
» See Plans and Pricing
Summary for Tradename: STRENSIQ
| Patents: | 2 |
| Applicants: | 1 |
| BLAs: | 1 |
| Suppliers: see list | 1 |
| Recent Clinical Trials: | See clinical trials for STRENSIQ |
Recent Clinical Trials for STRENSIQ
Identify potential brand extensions & biosimilar entrants
| Sponsor | Phase |
|---|---|
| Alexion Pharmaceuticals | Phase 2 |
Pharmacology for STRENSIQ
| Ingredient-type | Alkaline Phosphatase |
Patent Text Search: US Patents for STRENSIQ
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 001 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 001 | 2015-10-23 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 002 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 002 | 2015-10-23 | Start Trial | Corning Incorporated (Corning, NY) | 2031-10-25 | RX | Orphan | search |
| Alexion Pharm | STRENSIQ | asfotase alfa | SOLUTION;INJECTION | 125513 | 003 | 2015-10-23 | Start Trial | Alexion Pharmaceuticals, Inc. (Boston, MA) | 2035-01-28 | RX | Orphan | search |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
